Reduction of generalized tonic–clonic seizures following vagus nerve stimulation therapy: <scp>CORE</scp> ‐ <scp>VNS</scp> Study 24‐month follow‐up
Adjunctive VNS therapy was effective in reducing GTCS frequency in study participants. The sustained and consistent nature of the response further supports VNS as a long-term effective therapy in patients with DRE who have GTCS.
Authors
- Kathryn Nichol
- Mark R. Keezer (ORCID: https://orcid.org/0000-0002-2807-7347)
- Ryan Verner (ORCID: https://orcid.org/0000-0002-7364-7978)
- Ana Suller Martí (ORCID: https://orcid.org/0000-0002-8421-1125)
- Jorge G. Burneo (ORCID: https://orcid.org/0000-0002-3644-2826)
- Kenneth Alexis Myers (ORCID: https://orcid.org/0000-0001-7831-4593)
- Gaia Giannicola
- Andrea Andrade (ORCID: https://orcid.org/0000-0002-2735-7558)
- Martin Veilleux
Institutions
- Western University (CA)
- Montreal Neurological Institute and Hospital (CA)
- McGill University Health Centre (CA)
- LivaNova (United Kingdom) (GB)
- Université de Montréal (CA)
Publication Details
- Journal
- Epilepsia
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1111/epi.18371
- Citations
- 7
- Primary Topic
- Vagus Nerve Stimulation Research
- Type
- article
- Field-Weighted Citation Impact
- 5.90
Funders
- LivaNova